USPTO serial 79390081
T BD PHARMATECH
Reviewed by CopyMark Law Group
Status 774
- Filing date
- Status date
- Registration date
- —
- Examiner
- IM, JEAN H
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with T BD PHARMATECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
EE MING TRACEY BAHK
EE MING TRACEY BAHK OLIFF PLCP.O. BOX 320850ALEXANDRIA, VA 22320-4850UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical compounds and intermediates being chemical compounds, obtained by biotechnological processes for use in industry; biological preparations for use in industry and science; chemicals used in industry and science; chemicals for use in biotechnological product development; chemical diagnostic reagents for industrial purposes; reagents for scientific purposes; heat stable polymerase being biochemical preparations for use in industry and science; chemical reagents for use in diagnostic tests, other than for medical or veterinary use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; all aforementioned goods are not related with dietary, nutritional, vitamin supplements and preparations and vitamins | ACTIVE | — |
| 005 | Pharmaceuticals, medical and veterinary preparations for treatment of cancer, pain, bone diseases with anti-inflammatory, anti-nociceptive (pain-blocking), neuroprotective, anticonvulsant, antiviral and pre-anesthetical effects; sanitary preparations for medical purposes; material for stopping teeth, dental wax; disinfectants; vermin repelling preparations; fungicides, herbicides; medical and veterinary biological preparations for treatment of cancer, pain, bone diseases with anti-inflammatory, anti-nociceptive (pain-blocking), neuroprotective, anticonvulsant, antiviral and pre-anesthetical effects; biological reagents for veterinary use; biological reagents for medical use; enzymes for medical purposes; enzymes for veterinary purposes; medicinal active substances with incorporated intermediates, being medical preparations for treatment of cancer, pain, bone diseases with anti-inflammatory, anti-nociceptive (pain-blocking), neuroprotective, anticonvulsant, antiviral and pre-anesthetical effects; veterinary active substances with incorporated intermediates, being veterinary preparations for treatment of cancer, pain, bone diseases with anti-inflammatory, anti-nociceptive (pain-blocking), neuroprotective, anticonvulsant, antiviral and pre-anesthetical effects; diagnostic chemical reagents for medical use; diagnostic chemical reagents and media used in veterinary medicine; veterinary analysis reagents; medical analytical reagents; all aforementioned goods are not related with dietary, nutritional, vitamin supplements and preparations and vitamins | ACTIVE | — |
| 035 | Retail and wholesale store services for third parties of medical, veterinary, pharmaceutical, biotechnological chemicals and biopreparations used in industry and science, including via the internet; demonstration of goods; advertising services; business administration; all aforementioned services are not related with dietary, nutritional, vitamin supplements and preparations and vitamins | ACTIVE | — |
| 042 | Scientific research; advisory services relating to scientific research; scientific and technological services, namely research and design in the field of organic and analytical chemical preparations and design of chemical processes; industrial analysis of chemicals and research as a service in the field of organic and analytical chemistry; quality control for others; biotechnological studies related to chemical active substances and compounds and their intermediates; product research and development; biochemical research and development; biotechnology research and development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by osaühing TBD Pharmatech
- Other trademarks owned by osaühing TBD Pharmatech
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named T BD PHARMATECH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 21, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 3, 2026 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Apr 29, 2026 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Apr 28, 2026 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Apr 28, 2026 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Apr 22, 2026 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Apr 22, 2026 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Dec 3, 2025 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 4, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 4, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 29, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 2, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 2, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 2, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 2, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 2, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 10, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 10, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 10, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 22, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 4, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 4, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 4, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 10, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 3, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 3, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 3, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 25, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 2, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 2, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 11, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 10, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 27, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 23, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 22, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |